Lymphoma,MZL (Marginal Zone Lymphoma) Long-term Outcomes of Axi-cel CAR T-cell Therapy in iNHL Patients - ZUMA-5 Study Mar 01, 2023
Lymphoma,MZL (Marginal Zone Lymphoma) Research on Pirtobrutinib Safe and Effective for RT Patients with DLBCL Mar 01, 2023
FL (Follicular Lymphoma),Lymphoma,Popular Comparing HRQOL in R/R Large B-cell Lymphoma: Liso-cel vs SOC Feb 24, 2023
DLBCL (Diffuse Large B Cell Lymphoma),Lymphoma Polatuzumab Vedotin in First-Line DLBCL Treatment: Phase 3 POLARIX Trial Analysis in Asian Subpopulation Feb 24, 2023
CLL (Chronic Lymphocytic Leukemia),Leukemia,Lymphoma Comparing Relapsed or Refractory CLL with Zanubrutinib and Ibrutnib Phase 3 Trial Feb 16, 2023
FL (Follicular Lymphoma),Lymphoma Subcutaneous Epcoritamab Phase II Trial in Relapsed or Refractory Large B-Cell Lymphoma: Dose Expansion Study Feb 16, 2023
DLBCL (Diffuse Large B Cell Lymphoma),Lymphoma Ibrutinib Plus R-CHOP for BCL2 and MYC Co-Expressing DLBCL: Phase 3 Results from the PHOENIX Trial Feb 16, 2023
